Talk:Lamotrigine: Difference between revisions

Content deleted Content added

Inline

Latest revision as of 14:11, 27 June 2024

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Lamotrigine.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

This is the talk page for discussing improvements to the Lamotrigine article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL

Archives: 1, 2: 6 months

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine
Mid	This article has been rated as Mid-importance on the project's importance scale.

Pharmacology High‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology
High	This article has been rated as High-importance on the project's importance scale.

Sleep disturb % is misstated.

Not, "However, a retrospective study of 109 patients' medical records found that 6.7% of patients experienced an "alerting effect" resulting in intolerable insomnia, for which the treatment had to be discontinued. (65)"

It's only 6.4%.

65) Sadler M (March 1999). "Lamotrigine associated with insomnia". Epilepsia. 40 (3): 322–5. doi:10.1111/j.1528-1157.1999.tb00712.x. PMID 10080513. S2CID 43902298. 98.144.238.191 (talk) 17:28, 29 June 2022 (UTC)[reply]

How to take this medication. Empty stomach? With food? Time of day? Etc. 68.66.100.253 (talk) 14:36, 8 January 2024 (UTC)[reply]

Receptor activity listed in article not found in cited source

Receptor activity is listed as antagonistic at 5-HT3 and σ receptors with IC50 of 18 μM and 145 μM, respectively. The inline citation is [5] https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d7e3572d-56fe-4727-2bb4-013ccca22678. Neither the live webpage cited nor the archived version make any mention of antagonistic activity at 5-HT3 or σ receptors unless I'm mistaken. Moreover, the ligands section of the sigma receptor page lists Lamotrigine as an *agonist* of the σ receptors with two inline citations, one of which I can't access and the other of which makes no mention of activity at σ receptors at all. UriNation69420 (talk) 17:21, 26 June 2024 (UTC)[reply]

@@ Line 1: / Line 1: @@
 {{Reliable sources for medical articles}}
+{{talk header}}
-{{WikiProject Pharmacology|class=B|importance=high}}
-{{WikiProject Brands|class=|importance=}}
+{{WikiProject banner shell|class=B|
+{{WikiProject Medicine     |importance=mid}}
+{{WikiProject Pharmacology |importance=high}}
-{{notaforum|getting medical advice, reporting your symptoms and reactions to the drug, and so on.}}
-{{to do}}
+}}
+ {{User:MiszaBot/config
-{{Archive box|auto=long}}
-{{User:MiszaBot/config
 |archiveheader = {{atnhead|noredlinks=y}}
 |maxarchivesize = 40K
-|counter = 1
+|counter = 2
-|minthreadsleft = 0
+|minthreadsleft = 2
 |minthreadstoarchive = 0
-|algo = old(28d)
+|algo = old(180d)
 |archive = Talk:Lamotrigine/Archive %(counter)d
 }}
-{{Auto archiving notice |bot=MiszaBot I |age=28 |small=yes |dounreplied=yes}}
+== Sleep disturb % is misstated. ==
+Not, "However, a retrospective study of 109 patients' medical records found that 6.7% of patients experienced an "alerting effect" resulting in intolerable insomnia, for which the treatment had to be discontinued. (65)"
+It's only 6.4%.
+) Sadler M (March 1999). "Lamotrigine associated with insomnia". Epilepsia. 40 (3): 322–5. doi:10.1111/j.1528-1157.1999.tb00712.x. PMID 10080513. S2CID 43902298. [[Special:Contributions/98.144.238.191|98.144.238.191]] ([[User talk:98.144.238.191|talk]]) 17:28, 29 June 2022 (UTC)
+How to take this medication. Empty stomach? With food? Time of day? Etc. [[Special:Contributions/68.66.100.253|68.66.100.253]] ([[User talk:68.66.100.253|talk]]) 14:36, 8 January 2024 (UTC)
+== Receptor activity listed in article not found in cited source ==
+Receptor activity is listed as antagonistic at 5-HT3 and σ receptors with IC50 of 18 μM and 145 μM, respectively. The inline citation is [5] https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d7e3572d-56fe-4727-2bb4-013ccca22678. Neither the live webpage cited nor the archived version make any mention of antagonistic activity at 5-HT3 or σ receptors unless I'm mistaken. Moreover, the ligands section of the [[sigma receptor]] page lists Lamotrigine as an *agonist* of the σ receptors with two inline citations, one of which I can't access and the other of which makes no mention of activity at σ receptors at all. [[User:UriNation69420|UriNation69420]] ([[User talk:UriNation69420|talk]]) 17:21, 26 June 2024 (UTC)